Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zometa Label Adds Osteonecrosis Of The Jaw Precaution

Sep 30 2004

• By Andrew Kasper

Related Content

Off-Label Use Of Zometa For Osteoporosis Accounts For 5% Of Sales

Sep 16 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window